Literature DB >> 16183704

Antiexudative effects of opioids and expression of kappa- and delta-opioid receptors during intestinal inflammation in mice: involvement of nitric oxide.

Natalia Jiménez1, Margarita M Puig, Olga Pol.   

Abstract

The study evaluates the effects of kappa- (KOR), delta- (DOR), and mu-opioid receptor (MOR) agonists on the inhibition of plasma extravasation during acute and chronic intestinal inflammation in mice. The antiexudative effects of KOR and DOR agonists in animals treated with nitric oxide synthase (NOS) inhibitors and their protein levels in the gut (whole jejunum and mucosa) and spinal cord of mice with chronic intestinal inflammation were also measured. Inflammation was induced by the intragastric administration of one (acute) or two (chronic) doses of croton oil. Plasma extravasation was measured using Evans blue and protein levels by Western blot and immunoprecipitation. Plasma extravasation was significantly increased 2.7 times during chronic inflammation. The potency of the KOR agonist trans-3,4-dichloro-N-methyl-N-[2-(1-pyrrolydinyl)cyclohexyl]-benzeneazetamine (U50,488H) inhibiting plasma extravasation was enhanced 26.3 times during chronic compared with acute inflammation. [d-Pen(2),d-Pen(5)]-Enkephalin (DPDPE) (a DOR agonist) was also 11.8 times more potent during chronic inflammation, whereas the antiexudative effects of fentanyl (a MOR agonist) were not significantly altered. Receptor-specific antagonists reversed the effects. Protein levels of KOR and DOR in the whole jejunum and mucosa were significantly increased after chronic inflammation. Treatment with NOS inhibitors N(omega)-nitro-l-arginine methyl ester or l-N(6)-(1-iminoethyl)-lysine hydrochloride diminished plasma extravasation and inhibited the increased antiexudative effects of U50,488H and DPDPE during chronic intestinal inflammation. The data show that the enhanced antiexudative effects of KOR and DOR agonists could be related to an increased expression of KOR and DOR in the gut and that the release of nitric oxide may play a role augmenting the effects of opioids during chronic inflammation.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16183704     DOI: 10.1124/jpet.105.091991

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  11 in total

1.  Inhibitory effect of cannabichromene, a major non-psychotropic cannabinoid extracted from Cannabis sativa, on inflammation-induced hypermotility in mice.

Authors:  Angelo A Izzo; Raffaele Capasso; Gabriella Aviello; Francesca Borrelli; Barbara Romano; Fabiana Piscitelli; Laura Gallo; Francesco Capasso; Pierangelo Orlando; Vincenzo Di Marzo
Journal:  Br J Pharmacol       Date:  2012-06       Impact factor: 8.739

Review 2.  Endogenous opiates and behavior: 2006.

Authors:  Richard J Bodnar
Journal:  Peptides       Date:  2007-09-11       Impact factor: 3.750

3.  The peripheral administration of a nitric oxide donor potentiates the local antinociceptive effects of a DOR agonist during chronic inflammatory pain in mice.

Authors:  Arnau Hervera; Sergi Leánez; Roger Negrete; Olga Pol
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2009-07-28       Impact factor: 3.000

4.  The impact of tissue fixatives on morphology and antibody-based protein profiling in tissues and cells.

Authors:  Linda Paavilainen; Asa Edvinsson; Anna Asplund; Sophia Hober; Caroline Kampf; Fredrik Pontén; Kenneth Wester
Journal:  J Histochem Cytochem       Date:  2009-11-09       Impact factor: 2.479

5.  Local kappa opioid receptor activation decreases temporomandibular joint inflammation.

Authors:  Tânia C Chicre-Alcântara; Karla E Torres-Chávez; Luana Fischer; Juliana T Clemente-Napimoga; Vilma Melo; Carlos Amílcar Parada; Claudia Herrera Tambeli
Journal:  Inflammation       Date:  2012-02       Impact factor: 4.092

6.  Role of the δ-Opioid Receptor in 2 Murine Models of Colitis.

Authors:  Tia R Bobo; Leo R Fitzpatrick; Tiffany L Whitcomb; Timothy K Cooper; Sorana Raiciulescu; Jill P Smith
Journal:  Comp Med       Date:  2020-01-22       Impact factor: 0.982

7.  Peripheral effects of morphine and expression of μ-opioid receptors in the dorsal root ganglia during neuropathic pain: nitric oxide signaling.

Authors:  Arnau Hervera; Roger Negrete; Sergi Leánez; Jesús M Martín-Campos; Olga Pol
Journal:  Mol Pain       Date:  2011-04-12       Impact factor: 3.395

8.  Opioid System Modulates the Immune Function: A Review.

Authors:  Xuan Liang; Renyu Liu; Chunhua Chen; Fang Ji; Tianzuo Li
Journal:  Transl Perioper Pain Med       Date:  2016

9.  Characterization of the Synergistic Effect between Ligands of Opioid and Free Fatty Acid Receptors in the Mouse Model of Colitis.

Authors:  Agata Binienda; Adam Makaro; Marcin Talar; Julia B Krajewska; Aleksandra Tarasiuk; Adrian Bartoszek; Adam Fabisiak; Paula Mosińska; Karolina Niewinna; Katarzyna Dziedziczak; Mikołaj Świerczyński; Radzisław Kordek; Maciej Salaga; Jakub Fichna
Journal:  Molecules       Date:  2021-11-11       Impact factor: 4.411

Review 10.  The Useage of Opioids and their Adverse Effects in Gastrointestinal Practice: A Review.

Authors:  MahmoudReza Khansari; MasourReza Sohrabi; Farhad Zamani
Journal:  Middle East J Dig Dis       Date:  2013-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.